Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

7.86USD
12 Dec 2017
Change (% chg)

$-0.06 (-0.76%)
Prev Close
$7.92
Open
$8.02
Day's High
$8.02
Day's Low
$7.77
Volume
36,361
Avg. Vol
73,675
52-wk High
$9.22
52-wk Low
$3.76

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Mott

51 2017 Non-Executive Chairman of the Board

James Noble

55 2014 Chief Executive Officer, Director

Adrian Rawcliffe

45 2015 Chief Financial Officer

William Bertrand

52 2017 Chief Operating Officer

Gwendolyn Binder-Scholl

40 2016 Chief Technology Officer